Avenanthramides and avenacosides as biomarkers of oat intake: a pharmacokinetic study of solid and liquid oat consumption under single and repeated dose conditions
This study was registered at clinicaltrials.gov with the clinical trial number: NCT05511077, on August 22nd, 2022.
Authors
- Therese Karlsson (ORCID: https://orcid.org/0000-0002-8558-8338)
- Karsten Kristiansen (ORCID: https://orcid.org/0000-0002-6024-0917)
- Marina Armeni
- Elise Nordin (ORCID: https://orcid.org/0000-0001-5317-3261)
- Tim Cardilin (ORCID: https://orcid.org/0009-0008-5167-5055)
- Mats Jirstrand (ORCID: https://orcid.org/0000-0002-6612-8037)
- CB Jenkins
- Rikard Fristedt (ORCID: https://orcid.org/0000-0002-0979-6389)
- Otto Savolainen
- Panpan Qin (ORCID: https://orcid.org/0000-0002-7307-8736)
- Rikard Landberg (ORCID: https://orcid.org/0000-0002-8525-4194)
Institutions
- University of Copenhagen (DK)
- Medicon Village (SE)
- Fraunhofer Chalmers Research Centre for Industrial Mathematics (SE)
- Chalmers University of Technology (SE)
- IT University of Copenhagen (DK)
- University of Gothenburg (SE)
Publication Details
- Journal
- Nutrition Journal
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1186/s12937-025-01204-7
- Primary Topic
- Food Science and Nutritional Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chalmers Tekniska Högskola
- Science for Life Laboratory